News

CENTOGENE has received notification from the Nasdaq Stock Market LLC Listing Qualifications Department that it was not in compliance with the minimum…

The Company’s Pharma and CRO business development team and Diagnostics sales team will be attending events in the U.S. and Japan. CENTOGENE invites…

Adding significant financial expertise with an impressive track record in value creation

The Company’s Pharma and CRO business development team and Diagnostics sales team will be attending events in the U.S. and Spain. CENTOGENE invites…

Centogene N.V. (Nasdaq: CNTG), the essential life science partner for data-driven answers in rare and neurodegenerative diseases, today announced the…

Company management and the business development team will be attending events in the U.K. and Germany. CENTOGENE invites partners to schedule…

Working together with Denali Therapeutics to accelerate data-driven precision medicine for the PD community

Centogene N.V. (Nasdaq: CNTG), the commercial-stage essential biodata life science partner for rare and neurodegenerative diseases, today announced…